Skip to main content

Ethical Research When Abortion Access is Legally Restricted

June 23, 2023

UNC Bioethics and REDSSA Faculty Contribute Guest Editorship to South African Journal of Science

June 1, 2023
Stuart Rennie, PhD, and Keymanthri Moodley, PhD, co-PI’s of the Research for Ethical Data Science in Southern Africa (REDSSA) project, a collaboration between the UNC Center for Bioethics and Stellenbosch University in South Africa, served as guest editors in the recent special issue of the South African Journal of Science...

PROMPT Bioethics Study Team prepared White Paper

May 26, 2023
PROMPT Bioethics Study Team, Ann Dennis, MD, MS, Suzanne Day, PhD, MA; Stuart Rennie, PhD; and Kristen Sullivan, PhD. The Dennis Research Group in the School of Medicine has released a new white paper titled, “Revitalizing Community Engagement in the Public Health Use of Molecular HIV Epidemiology.”

Key Ethical Issues Encountered During COVID‑19 Research: A Thematic Analysis of Perspectives from South African Research Ethics Committees

February 15, 2023

Stakeholder Views on Informed Consent Models for Future Use of Biological Samples in Malawi and South Africa

January 19, 2023

Improving the Continuity of Care for People Living with HIV Experiencing Incarceration in North Carolina Jails: Stakeholder Perspectives.

September 1, 2022

Ethics and Regulatory Complexities Posed by a Pragmatic Clinical Trial: A Case Study from Lilongwe, Malawi

September 1, 2022

Advancing a Data Justice Framework for Public Health Surveillance

April 20, 2022

Attitudes About Analytic Treatment Interruption (ATI) in HIV Remission Trials with Different Antiretroviral Therapy (ART) Resumption Criteria

January 8, 2022
HIV remission trials often require temporary stopping of antiretroviral therapy (ART)—an approach called analytic treatment interruption (ATI). Trial designs resulting in viremia raise risks for participants and sexual partners. We conducted a survey on attitudes about remission trials, comparing ART resumption criteria (lower-risk “time to rebound” and higher-risk “sustained viremia”)...

Ethical Considerations for HIV Remission Clinical Research Involving Participants Diagnosed During Acute HIV Infection

December 28, 2021
HIV remission clinical researchers are increasingly seeking study participants who are diagnosed and treated during acute HIV infection—the brief period between infection and the point when the body creates detectable HIV antibodies. This earliest stage of infection is often marked by flu-like illness and may be an especially tumultuous period...